GlassScriptPhysician profile
Bryn Avery Anderson
NPI 1922638394
$1,158.91
in general payments reported to CMS, 2019-2025
19 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $146 · 2023: $297 · 2024: $467 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.43 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $204.59 | 2023-2025 | Stelara, Tremfya, Remicade |
| Leica Microsystems INC. | $134.36 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.52 | 2023-2024 | Trulance, Xifaxan |
| Phathom Pharmaceuticals, INC. | $107.42 | 2024 | Voquezna |
| Ardelyx, INC. | $106.62 | 2024-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $83.41 | 2024-2025 | Rezdiffra, Resmetirom |
| Abbvie INC. | $72.51 | 2023-2025 | |
| Gilead Sciences, INC. | $55.48 | 2023-2024 | |
| Celgene Corporation | $48.25 | 2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $35.84 | 2024-2025 | Eohilia |
| Myriad Genetic Laboratories, INC. | $31.17 | 2022-2023 | Myrisk |
| Nevro Corp. | $29.94 | 2024 | Senza |
| Mylan Specialty L.P. | $28.69 | 2024 | Yupelri |
| Lundbeck LLC | $27.55 | 2025 | Rexulti |
| Regeneron Healthcare Solutions, INC. | $22.04 | 2025 | Dupixent |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $19.93 | 2024 | |
| Exact Sciences Corporation | $15.24 | 2024 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $14.64 | 2024 | Pico 7, Renasys Touch |
| Shield Therapeutics INC | $13.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryn Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.